- Home
- / Cytogen
Cytogen
Stock Price
₩7.4 K
2024-10-28
Market Capitalization
₩180 B
2024-10-28
Revenue
₩10.9 B
FY, 2024
Cytogen Summary
Company Summary
- Overview
- Cytogen is a biotechnology company that develops CTC based liquid biopsy platform. It offers cancer drug monitoring, clinical research, pet cancer diagnosing, AI data analysis, and other services.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- KR | view all locations
- Website
- http://cytogenlab.com
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Seoul HQ
Korea (Republic of)
Beobwon-ro, Seocho-gu
Cytogen Financials
Summary Financials
- Revenue (FY, 2024)
- ₩10.9B
- Gross profit (FY, 2024)
- ₩1.7B
- Net income (FY, 2024)
- (₩17.1B)
- Cash (FY, 2024)
- ₩31.2B
- EBIT (FY, 2024)
- (₩14.0B)
- Enterprise value
- $163.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026